← Leaderboards
Javier Martin-Broto
University Of Texas Dallas
$366,004
Attributed
$1,098,012
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $558.1K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,098,012 · 1
By mechanism
R01$1,098,012 · 1
Top collaborators
- Leonidas Bleris3 shared
- Heather Naomi Hayenga3 shared
Most similar at University Of Texas Dallas
Same institution · by research overlap
- Leonidas Bleris$1,793,479
- Heather Naomi Hayenga$2,231,864
Others in their field
Other Rising Stars on “Adverse Effects”
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,500,724
- Dawn Fallacara · Battelle Centers/Pub Hlth Res & Evaluatn$12,449,418
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
Adverse EffectsAnatomyAngiogenesis InhibitorsAnimal ModelAntitumor EffectAreaBindingBiological MarkersBiomedical EngineeringBlood VesselsBoneBromodomainBromodomains And Extra-Terminal Domain InhibitorCancer BiologyCancer CenterCell ModelCentral Nervous SystemCharacteristicsChemotherapyChemotherapy-Oncologic ProcedureChimeric ProteinsChromosome 12Clinical ResearchAdult
Grant awards (3)
Bromodomain and extra-terminal motif (BET) inhibitors in Solitary fibrous tumor (SFT)$416,579
R01 · FY2025 · CA
Bromodomain and extra-terminal motif (BET) inhibitors in Solitary fibrous tumor (SFT)$141,522
R01 · FY2025 · CA
Bromodomain and extra-terminal motif (BET) inhibitors in Solitary fibrous tumor (SFT)$539,911
R01 · FY2024 · CA